Migraine and headache in children and adolescents: A 2026 evidence-based factsheet

Derya Uludüz1, Ishaq Abu-Arafeh2, Serena Laura Orr3

  • 1Department of Neurology, Istanbul Atlas University, Istanbul, Türkiye.

Insights

Headache disorders, including migraine, significantly impact children and adolescents globally, causing disability and affecting quality of life. Early, equitable care is crucial to prevent long-term health issues and improve brain health outcomes.

Area of Science:

  • Neurology
  • Public Health
  • Pediatrics

Background:

  • Headache disorders, especially migraine, are a leading cause of disability worldwide, often starting in childhood and adolescence.
  • Paediatric headache disorders are under-recognized and under-represented in global health policies.
  • These conditions significantly impact daily functioning and quality of life for young individuals.

Purpose of the Study:

  • To provide a comprehensive, developmentally informed overview of the global burden of headache disorders in children and adolescents.
  • To synthesize evidence on epidemiology, disability, impacts, risk factors, and management disparities.
  • To highlight urgent priorities for policy, advocacy, and research.

Main Methods:

  • Synthesis of evidence from population-based studies, systematic reviews, clinical cohorts.
  • Inclusion of Global Burden of Disease (GBD) 2023 point-prevalence estimates.
  • Analysis of key domains: epidemiology, disability, functional/psychosocial impacts, risk factors, treatment gaps, and management strategies, with attention to sociodemographic disparities.

Main Results:

  • Headache disorder prevalence increases with age, from 10.71% (5-9 years) to 42.64% (15-19 years).
  • Migraine prevalence rises from 2.79% to 18.08% in the same age groups.
  • Migraine is a leading cause of disability from early life, impairing school, social participation, and quality of life, with frequent comorbidities and inequitable access to care.

Conclusions:

  • Headache disorders in children and adolescents represent a major global public health challenge.
  • Early, equitable, and developmentally tailored care is essential to mitigate lifelong disability.
  • Addressing these disorders is crucial for improving global brain health outcomes.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...